About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Recent Patents on CNS Drug Discovery
›
top-articles
Recent Patents on CNS Drug Discovery
0.9
(top 50%)
impact factor
219
(top 50%)
papers
4.2K
(top 20%)
citations
35
(top 20%)
h
-index
0.9
(top 50%)
extended IF
268
all documents
4.3K
doc citations
52
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery
2012
196
2
The Injured Cochlea as a Target for Inflammatory Processes, Initiation of Cell Death Pathways and Application of Related Otoprotective Strategies
Recent Patents on CNS Drug Discovery
2010
120
3
Exosome-based strategies for Diagnosis and Therapy
Recent Patents on CNS Drug Discovery
2015
97
4
Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease
Recent Patents on CNS Drug Discovery
2010
94
5
Editorial :
Recent Patents on CNS Drug Discovery
2014
93
6
Modulation of Sirtuins: New Targets for Antiageing
Recent Patents on CNS Drug Discovery
2008
81
7
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Recent Patents on CNS Drug Discovery
2007
79
8
Galanthamine, a Natural Product for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery
2006
73
9
Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery
2009
69
10
Neuropeptide Y as an Endogenous Antiepileptic, Neuroprotective and Pro-Neurogenic Peptide
Recent Patents on CNS Drug Discovery
2006
65
11
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
Recent Patents on CNS Drug Discovery
2012
65
12
Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease
Recent Patents on CNS Drug Discovery
2012
64
13
Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery
2007
63
14
Inflammation: Beneficial or Detrimental After Spinal Cord Injury?
Recent Patents on CNS Drug Discovery
2008
62
15
Curcuminoids in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery
2012
59
16
Patented In Vitro Blood-Brain Barrier Models in CNS Drug Discovery
Recent Patents on CNS Drug Discovery
2011
58
17
Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery
2009
57
18
Therapeutic Potential of Cannabinoids in Schizophrenia
Recent Patents on CNS Drug Discovery
2014
57
19
Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery
2010
56
20
BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
Recent Patents on CNS Drug Discovery
2011
54
21
Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery
2009
54
22
TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
Recent Patents on CNS Drug Discovery
2006
52
23
Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
Recent Patents on CNS Drug Discovery
2011
52
24
Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
Recent Patents on CNS Drug Discovery
2006
50
25
Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery
Recent Patents on CNS Drug Discovery
2012
50
26
Rho-ROCK Inhibitors for the Treatment of CNS Injury
Recent Patents on CNS Drug Discovery
2007
44
27
Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery
2007
44
28
The Seek of Neuroprotection: Introducing Cannabinoids
Recent Patents on CNS Drug Discovery
2007
42
29
Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoids Activity by Preventing their Hydrolysis
Recent Patents on CNS Drug Discovery
2012
42
30
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery
2008
41
31
Therapeutic Potential of Adult Neural Stem Cells
Recent Patents on CNS Drug Discovery
2006
40
32
Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy
Recent Patents on CNS Drug Discovery
2008
40
33
Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Recent Patents on CNS Drug Discovery
2007
39
34
Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery
2014
39
35
The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
Recent Patents on CNS Drug Discovery
2009
36
36
Voltage-Gated Sodium Channel Blockers as Immunomodulators
Recent Patents on CNS Drug Discovery
2006
35
37
Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs
Recent Patents on CNS Drug Discovery
2007
35
38
Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery
2009
35
39
Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005
Recent Patents on CNS Drug Discovery
2006
33
40
Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia
Recent Patents on CNS Drug Discovery
2006
32
41
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Recent Patents on CNS Drug Discovery
2006
32
42
An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery
2006
32
43
New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors
Recent Patents on CNS Drug Discovery
2013
32
44
Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Recent Patents on CNS Drug Discovery
2008
31
45
Humanin; A Defender Against Alzheimers Disease?
Recent Patents on CNS Drug Discovery
2009
31
46
Therapeutic Treatment of Alzheimers Disease Using Metal Complexing Agents
Recent Patents on CNS Drug Discovery
2007
30
47
Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
Recent Patents on CNS Drug Discovery
2010
30
48
The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of Stroke
Recent Patents on CNS Drug Discovery
2013
29
49
Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery
2014
29
50
Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
Recent Patents on CNS Drug Discovery
2007
28
site/software ©
exaly
; All materials licenced under
CC by-SA
.